SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-180720
Filing Date
2010-08-06
Accepted
2010-08-06 11:14:38
Documents
6
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 705931
2 FIRST AMENDMENT TO DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT dex105.htm EX-10.5 25583
3 CERTIFICATION OF THE PRESIDENT AND CEO dex311.htm EX-31.1 9677
4 CERTIFICATION OF THE CFO AND TREASURER dex312.htm EX-31.2 9708
5 SECTION 906 PRESIDENT AND CEO CERTIFICATION dex321.htm EX-32.1 3810
6 SECTION 906 CFO AND TREASURER CERTIFICATION dex322.htm EX-32.2 3831
  Complete submission text file 0001193125-10-180720.txt   759959
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31577 | Film No.: 10996858
SIC: 2834 Pharmaceutical Preparations